ARTIVION, INC. AORT

Latest FY: 2025 Healthcare Medical Devices
Market Price $29.15
Market Cap $1.38B
P/E Ratio 138.81
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑13.6% YoY
$441.33M
3-Yr CAGR: 12.0%
Net Income ↑173.1% YoY
$9.77M
Net Margin: 2.2%
Free Cash Flow ↓-92.4% YoY
$839.00K
FCF Yield: 0.06%
EPS (Diluted) ↑165.6% YoY
$0.21
Basic: $0.22
Return on Equity Efficiency
2.2%
ROA: 23.0%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (AORT)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $180.4M $118.9M $10.8M $0.32 $19.7M $13.5M
FY 2017 $189.7M +5.2% $128.6M $3.7M -65.6% $0.11 -65.6% $10.8M $4.2M -69.2%
FY 2018 $262.8M +38.6% $173.0M $-2.8M -176.7% $-0.08 -172.7% $9.9M $4.1M -1.8%
FY 2019 $276.2M +5.1% $183.0M $1.7M +160.6% $0.05 +162.5% $15.8M $7.8M +89.4%
FY 2020 $253.2M -8.3% $167.8M $-16.7M -1,069.9% $-0.44 -980.0% $12.4M $5.0M -35.0%
FY 2021 $298.8M +18.0% $197.5M $-14.8M +11.1% $-0.38 +13.6% $-2.6M $-15.7M -411.0%
FY 2022 $313.8M +5.0% $202.5M $-19.2M -29.4% $-0.48 -26.3% $-5.2M $-14.2M +9.6%
FY 2023 $354.0M +12.8% $229.2M $-30.7M -59.9% $-0.75 -56.3% $18.8M $11.4M +180.4%
FY 2024 $388.5M +9.8% $248.8M $-13.4M +56.5% $-0.32 +57.3% $22.2M $11.0M -3.0%
FY 2025 $441.3M +13.6% $284.2M $9.8M +173.1% $0.21 +165.6% $39.9M $0.8M -92.4%
$

Valuation

Market Price $29.15
Market Cap $1.38B
Enterprise Value $1.53B
P/E Ratio 138.81
P/B Ratio 3.16
FCF Yield 0.06%
Dividend Yield 0.75%
Shares Outstanding 48,543,400
%

Profitability & Margins

Gross Margin 64.40%
Operating Margin 7.65%
Net Margin 2.21%
Return on Equity (ROE) 2.18%
Return on Assets (ROA) 22.96%
Asset Turnover 10.38x
Revenue 3-Yr CAGR 12.04%
🛡️

Financial Health & Liquidity

Current Ratio 2.59
Cash Ratio 3.95
Debt / Equity 0.480
Debt / Assets 5.057
Cash & Equivalents $64.91M
Total Debt $215.11M
Book Value / Share $9.23
💧

Cash Flow Efficiency

Operating Cash Flow $39.88M
Capital Expenditures (CapEx) $39.04M
Free Cash Flow $839.00K
OCF / Revenue 9.04%
FCF / Revenue 0.19%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $0.21
EPS (Basic) $0.22
Dividends / Share $0.22
Book Value / Share $9.23
EPS YoY Growth 165.62%
🏛️

Balance Sheet (FY 2025)

Total Assets $42.54M
Total Liabilities $16.45M
Stockholders' Equity $448.23M
Current Assets $42.54M
Current Liabilities $16.45M